Dr.
Jeffrey Roberts
MD, FRCSC
Clinical Professor
Division of Reproductive Endocrinology and Infertility
Biography
Dr. Jeffrey Roberts is Clinical Assistant Professor, UBC Departments of Obstetrics & Gynaecology and Anesthesiology, Pharmacology, & Therapeutics.
Dr. Roberts has BSc and MD degrees from the University of British Columbia. He completed his residency in Obstetrics and Gynecology at McGill University, then a fellowship in REI at the Center for Reproductive Medicine and Infertility at Weill Cornell Medical College of Cornell University. Upon completing his training, Dr. Roberts was appointed Assistant Professor in Obstetrics and Gynecology at Brown University in Providence, Rhode Island, where he served as a Reproductive Endocrinologist and Director of the Women and Infants Hospital of Rhode Island Egg Donation Program.
Presently Dr. Roberts works at the Pacific Centre for Reproductive Medicine with Drs. Bedawiy, Havelock, Seethream, and Tallon.
Dr Roberts is an active member of the Reproductive Medicine community in Canada and has served on the board of executives for Canadian Fertility and Andrology Society (CFAS) since 2008 as the National Continuing Professional Development Director, and the acting chair of the CFAS Fertility Preservation Special Interest Group.
Teaching
Research Interests/Skills
Dr. Roberts’ focus is on fertility preservation for cancer patients and IVF.
Publications
Roberts JE, MacLeod BA, Hollands RH. “Improved peribulbar anaesthesia with alkalinization and hyaluronidase”, Can J Anaesth; Sept 1993; 40(9): 835-838.
Roberts JE. “Peribulbar anaesthesia”, Can J Anaesth; Sept 1995; 42(9): 838-839.
Roberts JE, Clarke HJ, Tulandi T, Tan SL. “Effects of hydrosalpingeal fluid on murine embryo development and implantation”, J Assist Reprod Genet; 1999; 16(8): 421-424.
Roberts JE, Watkins KL, Tulandi T. “Effects of hypoestrogenism on adhesion formation and wound healing in the rat model”, J Am Assoc Gynecol Laparosc; Feb 2001; 8(1): 124-128.
Marino T, Roberts JE, McNamara H, Benjamin A. “Delayed interval of delivery in twin gestation revisited”, J SOGC, Feb 2001; 23(2): 149-154.
Fasouliotis, SJ, Spandorfer, SD, Witkin, S, Liu, H, Roberts, JE, Rosenwaks, Z. “Gamma-Interferon and IL-2 receptor levels predict the outcome of IVF pregnancies”, Hum Reprod, 2004; 19: 1357-63.
Fasouliotis, SJ, Spandorfer, SD, Witkin, S, Liu, H, Roberts, JE, Rosenwaks, Z. “Maternal serum vascular endothelial growth factor (VEGF) levels in early ectopic and intrauterine pregnancies following IVF treatment”, Fertil Steril, 2004; 82(2): 309-313.
Roberts JE, Spandorfer SD, Fasouliotis SJ, Rosenwaks Z. “A history of elevated basal follicle stimulating hormone (FSH) elevations is predictive of in vitro fertilization (IVF) outcome”, Fertil Steril, 2005; 83(1): 37-41.
Roberts JE, Spandorfer SD, Fasouliotis SJ, Lin K, Rosenwaks Z. “Follicle stimulating hormone (FSH) secreting pituitary adenoma causing spontaneous ovarian hyperstimulation syndrome”, Fertil Steril, 2005; 83(1): 208-210.
Roberts JE, Oktay K. “Fertility preservation: a comprehensive approach to the young woman with cancer”, J Natl Cancer Inst Monogr, 2005; 34:57-59.
Roberts JE. “History of elevated serum FSH and ovarian response”, Fertil Steril, 2005; 84(1): 260-261.
Roberts JE, Nikolopoulos SN, Giancotti F, Rosenwaks Z, and Oktay K. “Integrin beta-4 signaling plays a key role in mouse embryogenesis” (manuscript in process)
Roberts JE, “Toward an understanding of cellular behavior during in vitro fertilization (IVF)”, Women and Infants Hospital of Rhode Island IVF Newsletter, Summer 2005.
Roberts JE, Nikolopoulos SN, Giancotti F, Rosenwaks Z, and Oktay K. “Integrin beta-4 signaling plays a key role in mouse embryogenesis”, Reprod Sci 2009 Mar;16(3):286-93.
Shmorgun D, Claman P, Roberts JE (As member of Joint SOGC-CFAS Clinical Practice Guidelines Committee), “The diagnosis and management of ovarian hyperstimulation syndrome”, J Obstet Gynaecol Can 2011;33(11):1156-1162.
Roberts JE, Tallon N, Holtzer H, “Importance of fertility preservation counseling in young women with cancer”, CFAS Position Statement, 01/2014
Roberts JE, Ronn R, Tallon N, Holtzer H, “CFAS Clinical Practice Guideline: Fertility preservation in reproductive age woman facing gonadotoxic treatments” Curr Oncol, 2015;22(4):e294-e304.
Dunne C, Eghdami L, Roberts JE. “Hysteroscopic resection of Asherman’s Syndrome intrauterine adhesions to allow removal of a retained missed abortion”, J Min Invasive Gyncol 2014;21:S136-S190.
Eghdami L, Roberts JE, “Combined use of a GnRH agonist and antagonist for luteolysis in a breast cancer patient presenting in the late follicular phase for oocyte cryopreservation”, J Reprod Med (in press).
Dunne C, Roberts JE, “Growth hormone supplementation in luteal phase prior to microdose GnRH agonist flare protocol for in vitro fertilization”, J Obstet Gynaecol Can 2015;37(9):810-815.
Roberts JE, “Providing fertility preservation for young women with cancer is a team approach”, Creating Families 2015;10(1):22-25.
Dunne C, Roberts JE, “Social egg freezing: A viable option for fertility preservation”, BCMJ 2016;58(10):519-523.
CHAPTERS
Kligman I and Roberts JE. “Superovulation and intrauterine insemination”, Encyclopedia of Endocrine Diseases. Academic Press, 2004.
Pentland, S. Being Fertile – 10 Steps to Help You Overcome the Struggles of Infertility, Get Pregnant, and Create a Happy, Healthy Family. Foreword by Dr. Jeffrey Roberts. 2014.
Grants
Projects
Awards
ACOG Jr. Fellow Travel Award, McGill University, Montreal, Quebec August 1999
The Eric and Jane Molson Award for Excellence in Research, McGill University, Montreal, Quebec June 2000
Prize Paper – Best Basic Science Paper, Canadian Fertility and Andrology Society Conjoint Meeting – ASRM/CFAS, October 2005